BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15453845)

  • 1. Have choroidal and ciliary body melanomas changed during the period 1955-2000?
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):509-16. PubMed ID: 15453845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
    Augsburger JJ; Corrêa ZM; Freire J; Brady LW
    Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods].
    Libman ES; Brovkina AF; Bezrukov AV
    Oftalmol Zh; 1989; (6):336-8. PubMed ID: 2622596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
    Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
    Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brachytherapy in choroidal melanoma].
    Starzycka M; Słomska J; Romanowska B
    Klin Oczna; 1999; 101(1):19-22. PubMed ID: 10401209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central retinopathy associated with ciliary body and choroidal melanomas.
    Skalicky SE; Giblin M; Figueira EC; Conway RM
    Br J Ophthalmol; 2009 Jan; 93(1):45-6. PubMed ID: 19098044
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival after primary enucleation of largest uveal melanomas.
    Gambrelle J; Kodjikian L; Grange JD
    Acta Ophthalmol Scand; 2005 Jun; 83(3):398; 398-9. PubMed ID: 15948802
    [No Abstract]   [Full Text] [Related]  

  • 14. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
    Kivelä T; Puusaari I; Damato B
    Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circumstances of choroid and ciliary body melanoma detection].
    Frau E; Lautier-Frau M; Labétoulle M; Coquidet C; Kirsch O; Rumen F; Offret H
    J Fr Ophtalmol; 2003 Nov; 26(9):905-10. PubMed ID: 14631274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients.
    Damato B; Lecuona K
    Ophthalmology; 2004 May; 111(5):977-83. PubMed ID: 15121377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Attempts of orbit irradiation after enucleation of the eye with malignant choroidal melanoma. Part I].
    Mirkiewicz-Sieradzka B; Zygulska-Mach H; Romanowska B; Bryk J; Heitzman J; Ksiezyk M
    Klin Oczna; 1999; 101(4):287-90. PubMed ID: 10581897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uveal and conjunctival malignant melanoma in denmark 1943-97: observed and relative survival of patients followed through 2002.
    Isager P; Engholm G; Overgaard J; Storm H
    Ophthalmic Epidemiol; 2006 Apr; 13(2):85-96. PubMed ID: 16581612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.